Key result
Ethacizin reduced arrhythmias in dogs post-coronary ligation but increased QRS duration and R-on-T beats, resulting in sudden death in 33.3% of dogs compared to 0% with ethmozine or quinidine.
While ethacizin exhibits antiarrhythmic properties by reducing impulse initiation and conduction, it carries significant proarrhythmic and toxic risks, including increased QRS duration and sudden death.
Answers are grounded in this paper and cite their sources.
Raises safety concerns for ethacizin despite antiarrhythmic effects in dogs; leaves open its viability for human arrhythmia management.
Therapeutic and Toxic Effects of Ethacizin . Ethacizin is a new antiarrhythmic drug that is a derivative of ethmozine. We confirmed the early findings that ethacizin reduces the arrhythmias that occur in dogs 24 hours after ligation of the left anterior descending coronary artery. However, we found that QRS duration and R‐on‐T beats were increased by ethacizin, and that sudden death occurred in one‐third of the dogs. In control experiments, etbmozine (n = 6) and quinidine (n = 6) produced antiarrhythmic effects comparable to those of ethacizin, but sudden death did not occur. Studies then were carried out on canine cardiac tissues using standard microelectrode techniques. Ethacizin 300 ng/mL decreased dV/dt max in Purkinje fibers and ventricular muscle. These decreases were rate dependent. Ethacizin decreased action potential plateau duration (APD‐60 mV) in false tendon Purkinje fibers, and increased it in ventricular muscle. In spontaneously firing Purkinje fibers, ethacizin consistently decreased high‐potential (normal) and low‐potential (abnormal) automaticity to 14% and 12% of control, respectively. The effects of ethacizin on catecholamine‐enhanced high‐potential automaticity were more variable. Automaticity decreased in about half of the fibers, but did not change greatly in the remainder. The antiarrhythmic actions of ethacizin may result from reduction of impulse initiation or conduction in Purkinje fibers or myocardial cells. ( J Cardiovasc Electrophysiol, Vol. 1, pp. 411–425, October 1990 )
No takes yet. Share an insight, caveat, or question.
Dangman et al. (1990) studied Arrhythmias. Ethacizin vs. Ethmozine and quinidine was evaluated on Sudden death. Ethacizin reduced arrhythmias in dogs post-coronary ligation but increased QRS duration and R-on-T beats, resulting in sudden death in 33.3% of dogs compared to 0% with ethmozine or quinidine.
Synapse has enriched 10 related papers. Consider them for comparative context: